Clinical Trials Browser

Phase 1/2 × Primary Myelofibrosis × lestaurtinib × Clear all

NCT00668421 2014-11-26

CEP-701 (Lestaurtinib) in Myelofibrosis

Phase 1/2 Unknown

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis